COMPOSÉ HÉTÉROCYCLIQUE EN TANT QU'INHIBITEUR DE JAK, SES SELS ET LEUR UTILISATION THÉRAPEUTIQUE

• 收藏
• 分享

专利权人:

Ltd.;Tianjin Longbogene Pharmaceutical Co.

发明人:

ZHANG, Wenyan

申请号：

EP17833525

公开号：

EP3492468A4

申请日:

2017.07.25

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

Disclosed are a heterocyclic derivative as a JAK inhibitor, and salts thereof, wherein the definitions of (II), (III) and R are described in detail in the specification. In addition, also disclosed are a medicine comprising the compound and salts thereof as an active ingredient, and the use thereof in the preparation of a medicine for treating JAK-related target diseases, such as immune system diseases, rheumatoid arthritis and tumors.        Ⓐ     (II)        Ⓑ     (III)

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/